Insurance Coverage for MSD Korea's Singulair Now Expanded
Published: 2005-02-14 06:56:00
Updated: 2005-02-14 06:56:00
Effective February 1st, the National Health Insurance (NHI) eligible coverage for MSD Korea's Singulair, a leukotriene receptor antagonist medication primarily indicated for prevention and treatment of asthma symptoms, has been expanded.
The expanded insurance eligibility includes an added cov...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
